Topical Thymoquinone in Psoriasis Vulgaris
ConditionPsoriasis Vulgaris
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-60
SponsorAssiut University
About this trial
A previous trial found that N. sativa oil was more effective as an antipsoriatic agent, particularly when taken as both a cream and a pill. This confirmed that N. sativa possesses antipsoriatic properties and can alleviate psoriasis symptoms
Eligibility criteria
Qualifiers
Patients with clinical diagnosis of mild psoriasis vulgaris
Age: between 18 and 60 years' old
Patients who stopped any systemic therapy or phototherapy for at least 3 months and topical therapy for at least 4 weeks prior to enrollment
Disqualifiers
Psoriasis vulgaris involving > 10% of the body surface area, pustular or erythrodermic psoriasis.
Pregnant or lactating females.
Patients with any current dermatological disease.
Patients with any current systemic disease.
Trial design
Treatments tested in this trial
- Topical thymoquinone Ointment
- topical placebo ointment
Treatment groups
30 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov